260 related articles for article (PubMed ID: 24219812)
21. Hypopigmented mycosis fungoides associated with atopy in two children.
Onsun N; Kural Y; Su O; Demirkesen C; Büyükbabani N
Pediatr Dermatol; 2006; 23(5):493-6. PubMed ID: 17014650
[TBL] [Abstract][Full Text] [Related]
22. [Hypopigmented mycosis fungoides in children: a clinicopathological study of 6 cases].
Wang T; Liu YH; Zheng HY; Sun QN; Jin HZ; Li F; Fang K; Yan Y
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(46):3287-90. PubMed ID: 21223789
[TBL] [Abstract][Full Text] [Related]
23. Mycosis Fungoides: Experience in a Pediatric Hospital.
Cervini AB; Torres-Huamani AN; Sanchez-La-Rosa C; Galluzzo L; Solernou V; Digiorge J; Rubio P
Actas Dermosifiliogr; 2017; 108(6):564-570. PubMed ID: 28279399
[TBL] [Abstract][Full Text] [Related]
24. Frequency of hypopigmented mycosis fungoides in Egyptian patients presenting with hypopigmented lesions of the trunk.
Abdel-Halim M; El-Nabarawy E; El Nemr R; Hassan AM
Am J Dermatopathol; 2015 Nov; 37(11):834-40. PubMed ID: 26262921
[TBL] [Abstract][Full Text] [Related]
25. Hypopigmented macules secondary to imatinib for the treatment of chronic myeloid leukemia: a histopathologic and immunohistochemical study.
Llamas-Velasco M; Fraga J; Kutzner H; Steegmann JL; García-Diez A; Requena L
J Cutan Pathol; 2014 May; 41(5):417-26. PubMed ID: 24467724
[TBL] [Abstract][Full Text] [Related]
26. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.
Seif El Nasr H; Shaker OG; Fawzi MM; El-Hanafi G
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):103-8. PubMed ID: 22151832
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
28. Juvenile-onset hypopigmented mycosis fungoides mimicking vitiligo.
Ngo JT; Trotter MJ; Haber RM
J Cutan Med Surg; 2009; 13(4):230-3. PubMed ID: 19706233
[TBL] [Abstract][Full Text] [Related]
29. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study.
Rodney IJ; Kindred C; Angra K; Qutub ON; Villanueva AR; Halder RM
J Eur Acad Dermatol Venereol; 2017 May; 31(5):808-814. PubMed ID: 27515575
[TBL] [Abstract][Full Text] [Related]
30. [Hypopigmented mycosis fungoides].
Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
[TBL] [Abstract][Full Text] [Related]
31. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
32. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides.
Petit T; Cribier B; Bagot M; Wechsler J
Eur J Dermatol; 2003; 13(4):410-2. PubMed ID: 12948929
[TBL] [Abstract][Full Text] [Related]
34. Hypopigmented mycosis fungoides. Speculations about the mechanism of hypopigmentation.
Goldberg DJ; Schinella RS; Kechijian P
Am J Dermatopathol; 1986 Aug; 8(4):326-30. PubMed ID: 3766921
[TBL] [Abstract][Full Text] [Related]
35. Hypopigmented Mycosis Fungoides Mimicking Vitiligo.
Kim JC; Kim YC
Am J Dermatopathol; 2021 Mar; 43(3):213-216. PubMed ID: 33156019
[TBL] [Abstract][Full Text] [Related]
36. Comparison between the histopathological and immunophenotypical features of hypopigmented and nonhypopigmented mycosis fungoides: A retrospective study.
Jayasinghe DR; Dissanayake K; de Silva MVC
J Cutan Pathol; 2021 Apr; 48(4):486-494. PubMed ID: 32965737
[TBL] [Abstract][Full Text] [Related]
37. Mycosis fungoides with a CD56+ immunophenotype.
Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R
J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442
[TBL] [Abstract][Full Text] [Related]
38. Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases.
Ardigó M; Borroni G; Muscardin L; Kerl H; Cerroni L
J Am Acad Dermatol; 2003 Aug; 49(2):264-70. PubMed ID: 12894075
[TBL] [Abstract][Full Text] [Related]
39. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
40. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology.
Furlan FC; Sanches JA
An Bras Dermatol; 2013; 88(6):954-60. PubMed ID: 24474105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
